Evidence map›Paper›PMID 25658460›Full record

ReviewJournal of cardiovascular pharmacology2015

Regulation of phosphatidylinositol-specific phospholipase C at the nuclear envelope in cardiac myocytes.

Alan V Smrcka

Open access · greenAbstract readReview
In one paragraph

Review in Journal of cardiovascular pharmacology, 2015. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 9 papers.

0numbers the graph read from it
0cells of the map it votes in
9citing papers in PubMed
0.9field-weighted citation impact, top 25% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

9 citing papers in PubMed, 20 citations in OpenAlex.

  1. Review
  2. Article
  3. CaBiomolecules · 2024
    Review
  4. Review
  5. Article
  6. Article
  7. Review
  8. Article
  9. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

1 author at 1 institution in 1 country.

Alan V SmrckaDepartment of Pharmacology and Physiology, University of Rochester School of Medicine and Dentistry, Rochester, NY.
University of Rochester · US

Funding

SIGNAL TRANSDUCTION BY G PROTEINR01GM053536 · NIGMS · UNIVERSITY OF ROCHESTER · PI SMRCKA, ALAN V. · 1996 to 2018
$4.9M
Selective Targeting of G Protein beta gamma Subunits with Small MoleculesR01GM081772 · NIGMS · UNIVERSITY OF ROCHESTER · PI SMRCKA, ALAN V. · 2008 to 2017
$3.2M
Phosphatidylinositol 4-Phosphate Hydrolysis in Spatiotemporal Cell SignalingR01GM111735 · NIGMS · UNIVERSITY OF ROCHESTER · PI SMRCKA, ALAN V. · 2014 to 2017
$1.2M
NIGMS NIH HHS R01 GM053536NIGMS NIH HHS R01 GM081772NIGMS NIH HHS R01 GM111735
6 · The paper itself

Abstract

Phosphatidylinositol 4,5-bisphosphate hydrolysis at the plasma membrane by phospholipase C is one of the major hormone regulated intracellular signaling systems. The system generates the diffusible second messenger IP3 and the membrane bound messenger diacylglycerol. Spatial regulation of this system has been thought to be through specific subcellular distributions of the IP3 receptor or PKC. As is becoming increasingly apparent, receptor-stimulated signaling systems are also found at intracellular membranes. As discussed in this issue, G protein-coupled receptors have been identified at the nuclear envelope implying intracellular localization of the signaling systems that respond to G protein-coupled receptors. Here, we discuss the evidence for the existence of PLC signals that regulate nuclear processes, as well as the evidence for nuclear and nuclear envelope localization of PLC signaling components, and their implications for cardiac physiology and disease.

Indexed as

AnimalsEnzyme ActivationGolgi ApparatusHumansHydrolysisInositol 1,4,5-TrisphosphateMyocytes, CardiacNuclear EnvelopePhosphatidylinositol 4,5-DiphosphatePhosphatidylinositol PhosphatesReceptors, G-Protein-CoupledSecond Messenger SystemsType C PhospholipasesInositol 1,4,5-TrisphosphatePhosphatidylinositol 4,5-Diphosphatephosphatidylinositol 4-phosphatePhosphatidylinositol PhosphatesReceptors, G-Protein-CoupledType C Phospholipases

Identifiers

PMID25658460
PMCPMC4355108
OpenAlexW2314892395

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.